Curran Terrie's Form 4 filing
Arcutis Biotherapeutics, Inc. (ARQT) · filed Aug 24, 2026
- Accession no.
- 0001628280-26-058648
- Filed
- Aug 24, 2026, 4:19 PM ET
- Trade date
- Aug 20, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $27.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Curran TerrieCIK 0001690298 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | Common Stock | MOption exerciseAcquired | +1,072 | $7.51 | +$8,050.72 | 24,598 | Direct | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −1,072 | $26.04 | −$27,912.31 | 23,526 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | Common Stock | MOption exerciseDisposed | −1,072 | $0.00 | $0 | 11,148 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.